Melincoff Gwen A has filed 10 insider transactions across 4 companies since May 2023.
Most recent transaction: a grant/award of 7500 shares of Protalix BioTherapeutics, Inc. ($PLX) on September 03, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 3, 2025 | Protalix BioTherapeutics, Inc. | $PLX | Melincoff Gwen A | Not found | A | Common Stock | 7500 | $0.00 | 7,500.0000 | 81,271,610 | 9999.99% | 0.01% |
| Sept. 3, 2025 | Protalix BioTherapeutics, Inc. | $PLX | Melincoff Gwen A | Not found | A | Stock Options (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 81,271,610 | 9999.99% | 0.02% |
| June 24, 2025 | Gain Therapeutics, Inc. | $GANX | Melincoff Gwen A | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 28,685,417 | 9999.99% | 0.05% |
| June 24, 2024 | Gain Therapeutics, Inc. | $GANX | Melincoff Gwen A | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 17,978,951 | 9999.99% | 0.08% |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Melincoff Gwen A | Director | A | Common Stock | 7693 | $0.00 | 52,468.0000 | 41,438,466 | 17.18% | 0.02% |
| Sept. 29, 2023 | Protalix BioTherapeutics, Inc. | $PLX | Melincoff Gwen A | Not found | A | Stock Options (Right to Buy) | 61676 | $0.00 | 61,676.0000 | 83,200,641 | 9999.99% | 0.07% |
| June 23, 2023 | Gain Therapeutics, Inc. | $GANX | Melincoff Gwen A | Director | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 11,935,081 | 9999.99% | 0.09% |
| May 26, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Melincoff Gwen A | Director | A | Stock option (right to buy) | 10000 | $0.00 | 10,000.0000 | 8,397,088 | 9999.99% | 0.12% |
| May 25, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Melincoff Gwen A | Director | A | Stock option (right to buy) | 2666 | $0.00 | 2,666.0000 | 8,397,088 | 9999.99% | 0.03% |
| May 18, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Melincoff Gwen A | Director | A | Common Stock | 9792 | $0.00 | 44,775.0000 | 34,319,291 | 27.99% | 0.03% |